 |
|
Effect of Lowering of Homocysteine Levels on Inflammatory Markers
A Randomized Controlled Trial
Jane Durga, PhD;
L. J. H. van Tits, PhD;
Evert G. Schouten, MD, PhD;
Frans J. Kok, PhD;
Petra Verhoef, PhD
Arch Intern Med. 2005;165:1388-1394.
Background Elevated concentrations of homocysteine and low concentrations of folate may lead to a proinflammatory state that could explain their relation to vascular disease risk. We investigated the effect of lowering homocysteine concentrations by means of folic acid supplementation on markers of inflammation.
Methods In a double-blind, randomized, placebo-controlled trial among 530 men and postmenopausal women with homocysteine concentrations of 1.8 mg/L or higher ( 13 µmol/L) at screening, we investigated the effect of folic acid supplementation (0.8 mg/d) vs placebo for 1 year on serum concentrations of C-reactive protein, soluble intercellular adhesion molecule-1, oxidized low-density lipoprotein, and autoantibodies against oxidized low-density lipoprotein.
Results After 1 year of supplementation, concentrations of serum folate increased by 400% (95% confidence interval [CI], 362%-436%), and those of homocysteine decreased by 28% (95% CI, 24%-36%) in the folic acid group compared with the placebo group. However, no changes in plasma concentrations of the inflammatory markers were observed.
Conclusions Although homocysteine is associated with vascular disease risk in the general population, marked lowering of slightly elevated homocysteine concentrations by means of 1-year folic acid supplementation does not influence inflammatory responses involving C-reactive protein, soluble intercellular adhesion molecule-1, oxidized low-density lipoprotein, and autoantibodies against oxidized low-density lipoprotein.
Author Affiliations: Division of Human Nutrition, Wageningen University (Drs Durga, Schouten, Kok, and Verhoef), and Wageningen Centre for Food Sciences (Drs Durga and Verhoef), Wageningen, the Netherlands; and Department of General Internal Medicine, University Medical Center Nijmegen, Nijmegen, the Netherlands (Dr van Tits).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients
Akalin et al.
Eur J Endocrinol 2008;158:47-52.
ABSTRACT
| FULL TEXT
The Homocysteine Hypothesis of Depression
Folstein et al.
Am. J. Psychiatry 2007;164:861-867.
ABSTRACT
| FULL TEXT
Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease: Not Validated
Kaul et al.
J Am Coll Cardiol 2006;48:914-923.
ABSTRACT
| FULL TEXT
Dietary Factors That Promote or Retard Inflammation
Basu et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:995-1001.
ABSTRACT
| FULL TEXT
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bonaa et al.
NEJM 2006;354:1578-1588.
ABSTRACT
| FULL TEXT
Children of Alzheimer Patients: An Overview
Jarvik and Blazer
J Geriatr Psychiatry Neurol 2005;18:181-186.
|
